|
Status |
Public on Feb 22, 2018 |
Title |
SKBR3 Cells none treated rep2 |
Sample type |
genomic |
|
|
Source name |
SKBR3_none
|
Organism |
Homo sapiens |
Characteristics |
cell line: SKBR3 treated with: none
|
Treatment protocol |
SKBR3 and AU565 were treated by CAF-CMs or DAC as specified in the methods section
|
Growth protocol |
SKBR3 and AU565 cell lines were cultivated as the manufacturer’s instructions (ATCC).
|
Extracted molecule |
genomic DNA |
Extraction protocol |
Genomic DNA was extracted from cell lines using the QIAmp DNA Mini Kit (Qiagen)
|
Label |
Cy5 and Cy3
|
Label protocol |
Standard Illumina labelling protocol
|
|
|
Hybridization protocol |
Bisulphite converted DNA was amplified, fragmented and hybridised to Illumina Infinium Human Methylation450 Beadchip using standard Illumina protocol
|
Scan protocol |
Arrays were imaged using High Scan SQ using standard recommended Illumina scanner setting
|
Description |
SKBR3_none SK-1_-2
|
Data processing |
Genome Studio V2011.2 Signal_A and Signal_B intensities in idat files
|
|
|
Submission date |
Feb 27, 2017 |
Last update date |
Feb 22, 2018 |
Contact name |
Robert Dante |
E-mail(s) |
robert.dante@lyon.unicaner.fr
|
Phone |
+33478785922
|
Organization name |
Cancer Research Center – Lyon
|
Department |
Department of Tumoral Escape
|
Street address |
28, rue Laennec
|
City |
Lyon |
ZIP/Postal code |
69373 Lyon Cedex 08 |
Country |
France |
|
|
Platform ID |
GPL21145 |
Series (2) |
GSE95460 |
DNA methylation signature defines genes modulated by stromal cell contents of human breast tumors [MethylationEPIC] |
GSE95462 |
DNA methylation signature defines genes modulated by stromal cell contents of human breast tumors |
|